COMI:EGXCommercial International Bank - Egypt (CIB) S.A.E. Analysis
Data as of 2026-03-11 - not real-time
SEK 3.46
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Comintelli AB is trading just above its 20‑day SMA, which sits above the 50‑day SMA, reinforcing a bullish technical backdrop despite a MACD histogram that has turned negative and a decreasing volume trend that hints at waning short‑term enthusiasm. The RSI is perched in the mid‑60s, suggesting solid momentum without being overbought, while the price is hovering near a well‑defined support level and still below the next resistance tier, offering a modest upside cushion.
Fundamentally, the company is grappling with a steep revenue contraction of roughly 38% and operating margins that remain in the negative territory, yet it carries no debt, maintains a healthy cash buffer, and even generates positive free cash flow. The DCF model projects a fair value considerably higher than the current market price, and the price‑to‑book ratio sits above three, indicating potential undervaluation. Volatility is elevated at around 17% over the past month, but beta is comfortably below one, reflecting lower systematic risk. The firm offers no dividend, and its exposure is confined to the Swedish market, limiting regulatory and geographic headwinds.
Fundamentally, the company is grappling with a steep revenue contraction of roughly 38% and operating margins that remain in the negative territory, yet it carries no debt, maintains a healthy cash buffer, and even generates positive free cash flow. The DCF model projects a fair value considerably higher than the current market price, and the price‑to‑book ratio sits above three, indicating potential undervaluation. Volatility is elevated at around 17% over the past month, but beta is comfortably below one, reflecting lower systematic risk. The firm offers no dividend, and its exposure is confined to the Swedish market, limiting regulatory and geographic headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price is near immediate support, limiting downside
- Bearish MACD histogram signals short‑term pressure
- Decreasing volume reduces confidence in a breakout
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value substantially above current price
- Bullish SMA alignment and RSI strength
- Undervalued price‑to‑book relative to sector peers
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential upside from AI‑driven product roadmap
- Need to reverse negative margins and sustain cash generation
- Low debt and solid cash position provide a cushion for turnaround
Key Metrics & Analysis
Financial Health
Revenue Growth-38.20%
Profit Margin-17.26%
ROE-37.56%
ROA-7.81%
P/B Ratio3.0
Op. Cash FlowSEK-2146000
Free Cash FlowSEK4.0M
Industry P/E36.9
Technical Analysis
TrendBullish
RSI64.2
SupportSEK 3.30
ResistanceSEK 3.48
MA 20SEK 3.39
MA 50SEK 3.19
MA 200SEK 3.07
MACDBearish
VolumeDecreasing
Fear & Greed Index77.45
Valuation
Fair ValueSEK 5.84
GradeUndervalued
TypeValue
Risk Assessment
Beta0.56
Volatility16.79%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.